semaglutide increase heart rate & Rate: What You Should Know GLP-1s for Weight Loss: What

These medications not only assist patients in their journey to lose weight but also contribute to the management of associated health risk factors such as high blood pressure

However, under pathological conditions, activated MMPs are associated with increased degradation of ECM components and are involved in ECM re-modeling (Dollery et al., 2007)

Diabetologia 63 (10), 20572063

These outcomes underscore the potential clinical value of GLP-1 agonists in MASLD and MASH management. The scientists noted that due to some study limitations, including the researchs retrospective nature, further studies, following patients over time, will be needed to firmly establish how these medications affect major clinical events in people with MASLD or MASH